卡维地洛治疗48例慢性充血性心力衰竭疗效观察

The Carvedilol Treats 48 Example Chronic Congested Heart Failure the Curative Effect Observation

目的：探讨卡维地洛在慢性充血性心力衰竭（CHF）中的疗效。方法：将96例病情稳定无明显液体潴留的CHF患者随机分为治疗组和对照组，各48例。对照组予血管紧张索转移酶抑制剂（ACEI）、利尿剂和洋地黄制剂等常规治疗，治疗组在此基础上加用卡维地洛，随访6个月。对照观察治疗前后超声心动图、静息时心率、6min步行试验等以判断疗效。结果：治疗后心功能各项指标治疗组均优于对照组（P〈0．05）。结论：卡洛地洛治疗CHF有显著疗效。

Objective： To evaluate the effect of carvedilol in chronic congestive heart failure （CHF） patients. Methods： 96 cases no significant fluid retention medically stable CHF patients were randomly divided into treatment and control group, each 48 cases. To the control group of angiotensin - converting enzyme inhibitor （ACEI） , diuretics and digitalis and other conventional treatment. Treatment group based on the use of carvedilol, patients were followed up for 6 months. Contrast echocardiography before and after treatment, resting heart rate, the six - minute walk test, so as to judge the effiency. Results： Indicators of cardiac function after treatment were superior to the control group （ P 〈 0.05 ）. Conclusions： Treatment with CHF Carvedilol leads to significant effects.